Dr Martens PLC
LSE:DOCS

Watchlist Manager
Dr Martens PLC Logo
Dr Martens PLC
LSE:DOCS
Watchlist
Price: 76.9 GBX -1.09% Market Closed
Market Cap: 742.2m GBX
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Average
+11%
Revenue
Forecast
+5%
Operating Income
Forecast
+18%
Net Income
Forecast
+146%

Wall Street
Price Targets

DOCS Price Targets Summary
Dr Martens PLC

Wall Street analysts forecast DOCS stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for DOCS is 85.68 GBX with a low forecast of 66.66 GBX and a high forecast of 119.7 GBX.

DOCS Lowest Forecast
Wall Street Target
66.66 GBX
13% Downside
DOCS Average Forecast
Wall Street Target
85.68 GBX
11% Upside
DOCS Highest Forecast
Wall Street Target
119.7 GBX
56% Upside
Lowest
Price Target
66.66 GBX
13% Downside
Average
Price Target
85.68 GBX
11% Upside
Highest
Price Target
119.7 GBX
56% Upside
Dr Martens PLC Competitors:
Price Targets
9910
Feng Tay Enterprises Co Ltd
10% Upside
C
CCC
CCC SA
5% Upside
300979
Huali Industrial Group Co Ltd
34% Upside
NKE
Nike Inc
4% Downside
9910
Feng Tay Enterprises Co Ltd
10% Upside
C
CCC
CCC SA
5% Upside
300979
Huali Industrial Group Co Ltd
34% Upside
NKE
Nike Inc
4% Downside
RCKY
Rocky Brands Inc
14% Downside
DECK
Deckers Outdoor Corp
23% Upside
S
1836
Stella International Holdings Ltd
11% Upside
SKX
Skechers USA Inc
0% Upside

Revenue
Forecast

Revenue Estimate
Dr Martens PLC

For the last 6 years the compound annual growth rate for Dr Martens PLC's revenue is 10%. The projected CAGR for the next 3 years is 5%.

10%
Past Growth
5%
Estimated Growth
Estimates Accuracy
-1%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Dr Martens PLC

For the last 6 years the compound annual growth rate for Dr Martens PLC's operating income is -1%. The projected CAGR for the next 3 years is 18%.

-1%
Past Growth
18%
Estimated Growth
Estimates Accuracy
6%
Average Beat
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Dr Martens PLC

For the last 6 years the compound annual growth rate for Dr Martens PLC's net income is -20%. The projected CAGR for the next 3 years is 146%.

-20%
Past Growth
146%
Estimated Growth
Estimates Accuracy
-6%
Average Miss
What are analyst estimates?

See Also

Summary
DOCS intrinsic value, competitors valuation, and company profile.
DCF Valuation
DOCS stock valuation using Discount Cash Flow valuation method.
Relative Valuation
DOCS stock valuation using valuation multiples.
Wall Street Estimates
DOCS price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
DOCS stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is DOCS's stock price target?
Price Target
85.68 GBX

According to Wall Street analysts, the average 1-year price target for DOCS is 85.68 GBX with a low forecast of 66.66 GBX and a high forecast of 119.7 GBX.

What is Dr Martens PLC's Revenue forecast?
Projected CAGR
5%

For the last 6 years the compound annual growth rate for Dr Martens PLC's revenue is 10%. The projected CAGR for the next 3 years is 5%.

What is Dr Martens PLC's Operating Income forecast?
Projected CAGR
18%

For the last 6 years the compound annual growth rate for Dr Martens PLC's operating income is -1%. The projected CAGR for the next 3 years is 18%.

What is Dr Martens PLC's Net Income forecast?
Projected CAGR
146%

For the last 6 years the compound annual growth rate for Dr Martens PLC's net income is -20%. The projected CAGR for the next 3 years is 146%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 265,800+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.